Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

被引:46
作者
Dong, Wenjie
Chen, Xiaobing [2 ]
Xie, Jing [3 ]
Sun, Pinghu
Wu, Yunlin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China
[2] Henan Tumor Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Pathol, Rui Jin Hosp, Shanghai 200025, Peoples R China
关键词
gastric cancer; methylation; HAI-2/SPINT2; HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; RENAL-CELL CARCINOMA; HUMAN BREAST-CANCER; C-MET; OVARIAN-CANCER; PROTEASE INHIBITOR; BIKUNIN HAI-2/PB; MOUSE MODEL; EXPRESSION;
D O I
10.1002/ijc.25161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.
引用
收藏
页码:1526 / 1534
页数:9
相关论文
共 50 条
[21]   SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation [J].
Liu, Fei ;
Cox, Christopher D. ;
Chowdhury, Reshmi ;
Dovek, Laura ;
Nguyen, Huytram ;
Li, Tie ;
Li, Sichen ;
Ozer, Byram ;
Chou, Arthur ;
Nhung Nguyen ;
Wei, Bowen ;
Antonios, Joseph ;
Soto, Horacio ;
Kornblum, Harley ;
Liau, Linda ;
Prins, Robert ;
Nghiemphu, P. Leia ;
Yong, William ;
Cloughesy, Timothy ;
Lai, Albert .
JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) :423-434
[22]   N-glycosylation on Asn-57 is required for the correct HAI-2 protein folding and protease inhibitory activity [J].
Huang, Nanxi ;
Wang, Qiaochu ;
Chen, Chao-Yang ;
Hu, Je-Ming ;
Wang, Jehng-Kang ;
Chang, Ping-Ying ;
Johnson, Michael D. ;
Lin, Chen-Yong .
GLYCOBIOLOGY, 2023, 33 (03) :203-214
[23]   Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells [J].
Kim, TY ;
Jong, HS ;
Song, SH ;
Dimtchev, A ;
Jeong, SJ ;
Lee, JW ;
Kim, TY ;
Kim, NK ;
Jung, M ;
Bang, YJ .
ONCOGENE, 2003, 22 (25) :3943-3951
[24]   Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells [J].
Tai Young Kim ;
Hyun-Soon Jong ;
Sang-Hyun Song ;
Alexandre Dimtchev ;
Sook-Jung Jeong ;
Jung Weon Lee ;
Tae-You Kim ;
Noe Kyeong Kim ;
Mira Jung ;
Yung-Jue Bang .
Oncogene, 2003, 22 :3943-3951
[25]   MiR-381 functions as a tumor suppressor in gastric cancer by targeting ROCK2 [J].
Xie, Yilin ;
Qi, Jing ;
Zhu, Congbo ;
Zhao, Dingmin ;
Liao, Guoqing .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (01) :164-172
[26]   Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer [J].
II, Masanori ;
Yamamoto, Hiroyuki ;
Taniguchi, Hiroaki ;
Adachi, Yasushi ;
Nakazawa, Mayumi ;
Ohashi, Hirokazu ;
Tanuma, Tokuma ;
Sukawa, Yasutaka ;
Suzuki, Hiromu ;
Sasaki, Shigeru ;
Imai, Kohzoh ;
Shinomura, Yasuhisa .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (03) :593-599
[27]   Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer [J].
Otani, Koji ;
Li, Xiaoxing ;
Arakawa, Tetsuo ;
Chan, Francis K. L. ;
Yu, Jun .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (05) :445-455
[28]   Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer [J].
Park, Sung-Joon ;
Jang, Hay-Ran ;
Kim, Mirang ;
Kim, Jeong-Hwan ;
Kwon, Oh-Hyung ;
Park, Jong-Lyul ;
Noh, Seung-Moo ;
Song, Kyu-Sang ;
Kim, Seon-Young ;
Kim, Yeul-Hong ;
Kim, Yong Sung .
CARCINOGENESIS, 2012, 33 (08) :1494-1501
[29]   Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer [J].
Yu, J. ;
Ma, X. ;
Cheung, K. F. ;
Li, X. ;
Tian, L. ;
Wang, S. ;
Wu, C. W. ;
Wu, W. K. K. ;
He, M. ;
Wang, M. ;
Ng, S. S. M. ;
Sung, J. J. Y. .
ONCOGENE, 2010, 29 (49) :6464-6474
[30]   The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric Cancer [J].
Alejandra Alarcon, Maria ;
Olivares, Wilda ;
Cordova-Delgado, Miguel ;
Munoz-Medel, Matias ;
de Mayo, Tomas ;
Carrasco-Avino, Gonzalo ;
Wichmann, Ignacio ;
Landeros, Natalia ;
Amigo, Julio ;
Norero, Enrique ;
Villarroel-Espindola, Franz ;
Riquelme, Arnoldo ;
Garrido, Marcelo ;
Owen, Gareth, I ;
Corvalan, Alejandro H. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) :1-15